Correlations between vessel stiffness and biomarkers of senescent cell in elderly patients

Aim    To study the association between vascular wall stiffness and known markers for accumulation of senescent cells in blood, cells, and tissues of old patients.
Material and methods    This study included male and female patients aged 65 years and older who were referred to an elective surgical intervention, that included a surgical incision in the area of the anterior abdominal wall or large joints and met the inclusion and exclusion criteria. For all patients, traditional cardiovascular (CV) risk factors and arterial wall stiffness (pulse wave velocity, PWV) were evaluated. Also, biomaterials (peripheral blood, skin, subcutaneous adipose tissue) were collected during the surgery and were used for isolation of several cell types and subsequent histological analysis to determine various markers of senescent cells.
Results    The study included 80 patients aged 65 to 90 years. The correlation analysis identified the most significant indexes that reflected the accumulation of senescent cells at the systemic, tissue, and cellular levels (r>0.3, р<0.05) and showed positive and negative correlations with PWV. The following blood plasma factors were selected as the markers of ageing: insulin-like growth factor 1 (IGF-1), fibroblast growth factor 21 (FGF-21), and vascular endothelium adhesion molecule 1 (VCAM-1). A significant negative correlation between PWV and IGF-1 concentration was found. Among the tissue markers, P16INK, the key marker for tissue accumulation of senescent cells, predictably showed a positive correlation (r=0.394, p<0.05). A medium-strength correlation with parameters of the 96-h increment of mesenchymal stromal cells and fibroblasts and a weak correlation with IL-6 as a SASP (specific senescent-associated secretory phenotype) were noted. Results of the multifactorial linear regression analysis showed that the blood plasma marker, VCAM-1, and the cell marker, 96-h increment of fibroblasts, were associated with PWV regardless of the patient’s age.
Conclusion    Stiffness of great arteries as measured by PWV significantly correlates with a number of plasma, tissue, and cellular markers for accumulation of senescent cells. This fact suggests PWV as a candidate for inclusion in the panel of parameters for evaluation and monitoring of the biological age during the senolytic therapy.

1. St Sauver JL, Boyd CM, Grossardt BR, Bobo WV, Finney Rutten LJ, Roger VL et al. Risk of developing multimorbidity across all ages in an historical cohort study: differences by sex and ethnicity. BMJ Open. 2015;5(2):e006413. DOI: 10.1136/bmjopen-2014-006413

2. Kirkland JL. Translating the Science of Aging into Therapeutic Interventions. Cold Spring Harbor Perspectives in Medicine. 2016;6(3):a025908. DOI: 10.1101/cshperspect.a025908

3. Kirkland JL, Tchkonia T. Senolytic drugs: from discovery to translation. Journal of Internal Medicine. 2020;288(5):518–36. DOI: 10.1111/joim.13141

4. World Health Organization. A global brief of hypertension. Silent killer, global public health crisis: World Health Day 2013. 2013. [Av. at: https://www.who.int/publications/i/item/a-global-brief-on-hypertension-silent-killer-global-public-health-crisis-world-health-day-2013]

5. Özcan S, Alessio N, Acar MB, Mert E, Omerli F, Peluso G et al. Unbiased analysis of senescence associated secretory phenotype (SASP) to identify common components following different genotoxic stresses. Aging. 2016;8(7):1316–29. DOI: 10.18632/aging.100971

6. Baker DJ, Childs BG, Durik M, Wijers ME, Sieben CJ, Zhong J et al. Naturally occurring p16Ink4a-positive cells shorten healthy lifespan. Nature. 2016;530(7589):184–9. DOI: 10.1038/nature16932

7. Kirkland JL, Tchkonia T. Cellular Senescence: A Translational Perspective. EBioMedicine. 2017;21:21–8. DOI: 10.1016/j.ebiom.2017.04.013

8. Liu Y, Sanoff HK, Cho H, Burd CE, Torrice C, Ibrahim JG et al. Expression of p16INK4a in peripheral blood T-cells is a biomarker of human aging. Aging Cell. 2009;8(4):439–48. DOI: 10.1111/j.1474-9726.2009.00489.x

9. Spazzafumo L, Mensà E, Matacchione G, Galeazzi T, Zampini L, Recchioni R et al. Age-related modulation of plasmatic beta-Galactosidase activity in healthy subjects and in patients affected by T2DM. Oncotarget. 2017;8(55):93338–48. DOI: 10.18632/oncotarget.21848

10. Moslehi J, DePinho RA, Sahin E. Telomeres and Mitochondria in the Aging Heart. Circulation Research. 2012;110(9):1226–37. DOI: 10.1161/CIRCRESAHA.111.246868

11. Salminen A, Kaarniranta K, Kauppinen A. Insulin/IGF-1 signaling promotes immunosuppression via the STAT3 pathway: impact on the aging process and age-related diseases. Inflammation Research. 2021;70(10–12):1043–61. DOI: 10.1007/s00011-021-01498-3

12. Vitale G, Pellegrino G, Vollery M, Hofland LJ. ROLE of IGF-1 System in the Modulation of Longevity: Controversies and New Insights from a Centenarians’ Perspective. Frontiers in Endocrinology. 2019; 10:27. DOI: 10.3389/fendo.2019.00027

13. Matjusaitis M, Chin G, Sarnoski EA, Stolzing A. Biomarkers to identify and isolate senescent cells. Ageing Research Reviews. 2016;29:1–12. DOI: 10.1016/j.arr.2016.05.003

14. Birch J, Gil J. Senescence and the SASP: many therapeutic avenues. Genes & Development. 2020;34(23–24):1565–76. DOI: 10.1101/gad.343129.120

15. Mikael L de R, Paiva AMG de, Gomes MM, Sousa ALL, Jardim PCBV, Vitorino PV de O et al. Vascular Aging and Arterial Stiffness. Arquivos Brasileiros de Cardiologia. 2017;109(3):253–8. DOI: 10.5935/abc.20170091

16. Kobalava Zh.D., Konradi A.O., Nedogoda S.V., Shlyakhto E.V., Arutyunov G.P., Baranova E.I. et al. Arterial hypertension in adults. Clinical guidelines 2020. Russian Journal of Cardiology. 2020;25(3):149–218. DOI: 10.15829/1560-4071-2020-3-3786

17. Vlachopoulos C, Terentes-Printzios D, Laurent S, Nilsson PM, Protogerou AD, Aznaouridis K et al. Association of Estimated Pulse Wave Velocity with Survival: A Secondary Analysis of SPRINT. JAMA Network Open. 2019;2(10):e1912831. DOI: 10.1001/jamanetworkopen.2019.12831

18. Tkachenko Yu.V., Strazhesko I.D., Borisov E.N., Plisiuk A.G., Orlova Ya.A. Adaptation of the method of pulse wave velocity measurement for screening examinations in outpatient practice. Journal of Clinical Practice. 2019;10(1):48–56. DOI: 10.17816/clinpract10148-56

19. Sorokina A.G., Orlova Ya.A., Grigorieva O.A., Novoseletskaya E.S., Basalova N.A., Alexandrushkina N.A. et al. Creation of a collection of different biological sample types from elderly patients to study the relationship of clinical, systemic, tissue and cellular biomarkers of accumulation of senescent cells during aging. Cardiovascular Therapy and Prevention. 2021;20(8):164–75. DOI: 10.15829/1728-8800-2021-3051

20. Avolio AP, Kuznetsova T, Heyndrickx GR, Kerkhof PLM, Li JK-J. Arterial Flow, Pulse Pressure and Pulse Wave Velocity in Men and Women at Various Ages. Advances in Experimental Medicine and Biology. 2018;1065:153–68. DOI: 10.1007/978-3-319-77932-4_10

21. Battistoni A, Michielon A, Marino G, Savoia C. Vascular Aging and Central Aortic Blood Pressure: From Pathophysiology to Treatment. High Blood Pressure & Cardiovascular Prevention. 2020;27(4):299–308. DOI: 10.1007/s40292-020-00395-w

22. Johnson SC. Nutrient Sensing, Signaling and Ageing: The Role of IGF-1 and mTOR in Ageing and Age-Related Disease. Subcell Biochemistry. 2018;90:49–97. DOI: 10.1007/978-981-13-2835-0_3

23. Chisalita SI, Johansson GS, Liefvendahl E, Bäck K, Arnqvist HJ. Human aortic smooth muscle cells are insulin resistant at the receptor level but sensitive to IGF1 and IGF2. Journal of Molecular Endocrinology. 2009;43(6):231–9. DOI: 10.1677/JME-09-0021

24. Planavila A, Redondo-Angulo I, Villarroya F. FGF21 and Cardiac Physiopathology. Frontiers in Endocrinology. 2015;6:133. DOI: 10.3389/fendo.2015.00133

25. Planavila A, Redondo-Angulo I, Ribas F, Garrabou G, Casademont J, Giralt M et al. Fibroblast growth factor 21 protects the heart from oxidative stress. Cardiovascular Research. 2015;106(1):19–31. DOI: 10.1093/cvr/cvu263

26. Joki Y, Ohashi K, Yuasa D, Shibata R, Ito M, Matsuo K et al. FGF21 attenuates pathological myocardial remodeling following myocardial infarction through the adiponectin-dependent mechanism. Biochemical and Biophysical Research Communications. 2015;459(1):124–30. DOI: 10.1016/j.bbrc.2015.02.081

27. Rupérez C, Lerin C, Ferrer-Curriu G, Cairo M, Mas-Stachurska A, Sitges M et al. Autophagic control of cardiac steatosis through FGF21 in obesity-associated cardiomyopathy. International Journal of Cardiology. 2018;260:163–70. DOI: 10.1016/j.ijcard.2018.02.109

28. Cardoso AL, Fernandes A, Aguilar-Pimentel JA, de Angelis MH, Guedes JR, Brito MA et al. Towards frailty biomarkers: Candidates from genes and pathways regulated in aging and age-related diseases. Ageing Research Reviews. 2018;47:214–77. DOI: 10.1016/j.arr.2018.07.004

29. Tezze C, Romanello V, Sandri M. FGF21 as Modulator of Metabolism in Health and Disease. Frontiers in Physiology. 2019;10:419. DOI: 10.3389/fphys.2019.00419

30. Chen W, Tian B, Liang J, Yu S, Zhou Y, Li S. Matrix stiffness regulates the interactions between endothelial cells and monocytes. Biomaterials. 2019;221:119362. DOI: 10.1016/j.biomaterials.2019.119362

31. Srivastava P, Badhwar S, Chandran DS, Jaryal AK, Jyotsna VP, Deepak KK. Imbalance between Angiotensin II - Angiotensin (1- 7) system is associated with vascular endothelial dysfunction and inflammation in type 2 diabetes with newly diagnosed hypertension. Diabetes & Metabolic Syndrome: Clinical Research & Reviews. 2019;13(3):2061–8. DOI: 10.1016/j.dsx.2019.04.042

32. Stanifer JW, Landerman L, Pieper CF, Huffman KM, Kraus WE. Relations of established aging biomarkers (IL-6, D-dimer, s-VCAM) to glomerular filtration rate and mortality in community-dwelling elderly adults. Clinical Kidney Journal. 2018;11(3):377–82. DOI:10.1093/ckj/sfx097

33. Villarroya J, Gallego-Escuredo JM, Delgado-Anglés A, Cairó M, Moure R, Gracia Mateo M et al. Aging is associated with increased FGF21 levels but unaltered FGF21 responsiveness in adipose tissue. Aging Cell. 2018;17(5):e12822. DOI: 10.1111/acel.12822

34. Richter V, Rassoul F, Purschwitz K, Hentschel B, Reuter W, Kuntze T. Circulating Vascular Cell Adhesion Molecules VCAM-1, ICAM-1 and E-Selectin in Dependence on Aging. Gerontology. 2003;49(5):293–300. DOI: 10.1159/000071710

35. Jia G, Aroor AR, Jia C, Sowers JR. Endothelial cell senescence in aging-related vascular dysfunction. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease. 2019;1865(7):1802–9. DOI: 10.1016/j.bbadis.2018.08.008

36. Shimizu I, Minamino T. Cellular senescence in cardiac diseases. Journal of Cardiology. 2019;74(4):313–9. DOI: 10.1016/j.jjcc.2019.05.002

37. Bruder SP, Jaiswal N, Haynesworth SE. Growth kinetics, self-renewal, and the osteogenic potential of purified human mesenchymal stem cells during extensive subcultivation and following cryopreservation. Journal of Cellular Biochemistry. 1997;64(2):278–94. DOI: 10.1002/(SICI)1097-4644(199702)64:2<278::AID-JCB11>3.0.CO;2-F

38. Dodig S, Čepelak I, Pavić I. Hallmarks of senescence and aging. Biochemia medica. 2019;29(3):483–97. DOI: 10.11613/BM.2019.030501